More Ways to Connect
  LinkedIn Twitter YouTube Instagram

University of Cincinnati Academic Health Center
Publish Date: 09/04/01
Media Contact: AHC Public Relations, (513) 558-4553
PDF download
RSS feed
related news
share this
Study of New Spermicide Seeks Volunteers

Cincinnati--Michael Thomas, MD, Professor of Obstetrics and Gynecology, UC College of Medicine,and co-director of the UC Center for Reproductive Medicine Research, has received a $421,000 grant from the National Institutes of Health (NIH) to study a new spermicide. The purpose of this study is to compare a new spermicide with an over-the-counter spermicide. The spermicides will be used with a diaphragm and the products will be compared for effectiveness and side effects.

Participants will be required to use this as their primary method of birth control. The nationwide study will involve 975 female subjects. Study participation will last six menstrual cycles or approximately seven months. Women in this clinical trial will be 18 to 40 years old, with no known allergy or sensitivity to spermicide gels or products containing latex. Women cannot participate in this research if they have used Depo-Provera in the past ten months, are pregnant or breast-feeding. Women should be generally healthy and not diagnosed with sexually transmitted diseases in the previous six months. Participants will be compensated for their time.

For more information or to see if you qualify for this study, please call (513) 584-4100.

 back to list | back to top